Endothelin-1 levels in the pathophysiology of chronic obstructive pulmonary disease and bronchial asthma

Respiratory Medicine

Volumn 97, Issue 8, 2003, Pages 983-989

  Spiropoulos, K ^a   Trakada, G ^a   Nikolaou, E ^b   Prodromakis, E ^a   Efremidis, G ^a   Pouli, A ^c   Koniavitou, A ^b  

^a UNIVERSITY OF PATRAS   (Greece)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

^c Agios Savvas Cancer Hospital   (Greece)

Author keywords

Bronchial asthma; Chronic obstructive pulmonary disease (COPD); Endothelin 1 (ET 1); Sleep study

Indexed keywords

ENDOTHELIN 1; OXYHEMOGLOBIN;

ADULT; AGED; ARTERIAL BLOOD; ARTICLE; ASTHMA; BLOOD OXYGEN TENSION; BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROCARDIOGRAM; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE OXIMETER; RESPIRATORY AIRFLOW; SLEEP; SLEEP APNEA SYNDROME;

EID: 0043133463     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(03)00129-X     Document Type: Article

References (43)

1. Innove A, Yanagisawa S, Kimura Y, et al. The human endothelin family; three structurally and pharmacologically distinct isopeptides predictor by three separate genes. Proc Natl Acad Sci USA 1989;86:2863-7.
2. Vittori E, Marini M, Fasoli A, et al. Increased expression of endothelin in bronchial epithelial cell of asthmatic patients and effect of corticosteroids. Am Rev Respir Dis 1992;146:1320-5.
3. Mullol J, Baraniuk JN, Logun C, et al. Endothelin-1 induces GM-CSF, IL-6 and IL-8 but not G-CSF release from a human epithelial cell line (BEAS-ZB). Neuropeptides 1996;30:551-5.
4. Goldie RG, Henry PJ, Paterson JMH, et al. Contractile effects and receptor distributions for endothelin-1 in human and animal airways. Agents Actions 1990;31(Suppl): S229-32.
5. Langente V, Chabrier PE, Mencia-Huerta JM, et al. Pharmacological modulation of the bronchopulmonary action of the vasoactive peptide, endothelin, administered by aerosol in the guinea-pig. Biochem Biophys Res Commun 1989;158:625-32.
6. Finsnes F, Lyberg T, Christensen G, et al. Leukotriene antagonism reduces the generation of endothelin-1 and inert gamma and inhibits eosinophilic airway inflammation. Respir Med 2002;96(11):901-6.
7. Fujitani Y, Ninimiya H, Okada T, et al. Suppression of endothelin-1 induced mitogenic responses of human aorti smooth muscle cells by interleukin-1 beta. J Clin Invest 1995;6:2474-82.
8. Hay D, Henry PJ, Goldie RG. Is endothelin-1 a mediator in asthma? Am J Respir Crit Care Med 1996;154:1594-7.
9. Trakada G, Tsourapis S, Marangos M, et al. Arterial and bronchoalveolar lavage fluid endothelin-1 concentration in asthma. Respir Med 2000;94:992-6.
10. Chen Y-F, Oparil S. Endothelial dysfunction in the pulmonary vascular bed. Am J Med Sci 2000;320:223-32.
11. Luscher TF, Barton M. Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs. Circulation 2000;102:2434-40.
12. Voelkel NF, Tuder RM. Hypoxia-induced pulmonary vascular remodeling: a model for what human disease? J Clin Invest 2000;106:733-8.
13. Jankov RP, Cabacungan J, Belcastro R, et al. Endothelin-1 and O2 mediated pulmonary hypertension in neonatal rats: a role for products in lipid peroxidation. Pediatr Res 2000; 48:289-98.
14. Cherniack N. Wake up sleepy head: steep can be dangerous. Respiration 2001;68:129-30.
15. Trask CH, Gree EM. Oximeter studies on patients with chronic obstructive emphysema, awake and during sleep. N Engl J Med 1962;266:639-42.
16. Koo KW, Sax DS, Snider GL. Arterial blood gases and pH during sleep in chronic obstructive pulmonary disease. Am J Med 1975;58:663-70.
17. Wynne JW, Block AJ, Hemenway I, et al. Disordered breathing and oxygen desaturation during sleep in patients with chronic obstructive lung disease (COLD). Am J Med 1979;66:573-9.
18. Trakada G, Marangos M, Spiropoulos K. Mechanisms of endothelin-1 elevation in chronic obstructive pulmonary disease patients with noctural oxyhemoglobin desaturation. Respiration 2001;68(2):134-9.
19. Francis PWJ, Muller NL, Guitwitx D, et al. Hemoglobin desaturation: its occurrence during sleep in patients with cystic fibrosis. Am J Dis Child 1980;134:734-40.
20. Stokes DC, McBride JT, Wall MA, et al. Sleep hypoxemia in young adults with cystic fibrosis. Dis Child 1980;134:741-3.
21. Bye PT, Issa F, Bethan-Jones M, et al. Studies of oxygenation during sleep in patients with interstitial lung disease. Am Rev Respir Dis 1984;129:27-32.
22. Perez-Padilla R, West P, Lertzman M, et al. Breathing during sleep in patients with interstitial lung disease. Am Rev Respir Dis 1985;132:224-9.
23. Mezon BL, West P, Israels J, et al. Sleep breathing abnormalities in kyphoscotiosis. Am Rev Respir Dis 1980; 122:617-21.
24. Guilleminault C, Motta J. Sleep apnea syndrome as a long term sequela of poliomyelitis. In: Guilleminault C, Dement WC, editors. Sleep apnea syndromes. New York: Alan R Liss, 1978. p. 309-15.
25. Douglas NJ, Calverley PM, Legget RJ, et al. Transient hypoxemia during sleep in chronic bronchitis and emphysema. Lancet 1979;1:1-4.
26. Boysen PG, Block JA, Wynne JW, et al. Nocturnal pulmonary hypertension in patients with obstructive pulmonary disease. Chest 1979;76:536-42.
27. Fletcher EC, Levin DC. Cardiopulmonary haemodynamics during sleep in subjects with chronic obstructive pulmonary disease: the effect of short and long term oxygen. Chest 1984;85:6-14.
28. Flenley DC. Clinical hypoxia: causes, consequences and correction. Lancet 1978;1:542-6.
29. Block AJ, Boyson PG, Wynne JW. The origins of cor pulmonale, an hypothesis. Chest 1979;75:109.
30. Global Initiative for Chronic Obstructive Lung Disease, National Institutes of Health. National Heart, Lung, and Blood Institute.
31. Updated from the NHLBI/WH0 Workshop report: global strategy for asthma management and prevention. Issued January 1995.
32. Chai HR, Farr LA, Froehlich DA, et al. Standarization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975;56:323-7.
33. Rechtshaffen A, Kales A, editors. A manual of standardized terminology, techniques and scoring system for sleep stages of human subject. Washington: NIH publication 204, 1968.
34. Nakano J, Takizawa H, Ohtoshi T, et al. Endotoxin and pro-inflammatory cytokines stimulate endothelin-1 expression and release by airway epithelial cells. Clin Exp Allergy 1994; 24:330-6.
35. Faller DV. Endothelial cell responses to hypoxic stress. Clin Exp Pharmacol Physiol 1999;26:74-84.
36. Moraes DL, Colucci WS, Givertz MM. Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management. Circulation 2000;102:1718-23.
37. Larson LG, Lindberg A, Lundback B, et al. Symptoms related to obstructive sleep apnoea are common in subjects with asthma, chronic bronchitis and rhinitis in a general population. Respir Med 2001;95(5):423-9.
38. Fletcher EC, Gray BA, Levin DC. Nonapneic mechanism of arterial oxygen desaturation during rapid-eye-movement sleep. J Appl Physiol 1983;54:632-9.
39. Hudgel DW, Martin RJ, Capehart M, et al. Contribution of hypoventilation to sleep oxygen desaturation in chronic obstructive pulmonary disease. J Appl Physiol 1983;55:669-77.
40. Fletcher EC. Sleep breathing and oxyhemoglobin saturation in chronic lung disease. In: Fletcher EC, editor. Abnormalities of respiration during sleep: diagnosis, pathophysiology and treatment. Orlando: Grune & Stratton, 1986. p. 155-79.
41. Ferri C, Bellini C, Angelis C, et al. Circulating endothelin-1 concentration in patients with chronic hypoxia. J Clin Pathol 1995;48:519-24.
42. Cargill RI, Kiely DG, Clark RA, et al. Hypoxaemia and release of endothelin-1. Thorax 1995;50:1308-10.
43. Minh VD, Lee HM, Dolan GF, et al. Hypoxemia during exercise in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1979;120:787-94.